Denmark· DK-28104919111
Fostimon Set
A urofollitropin product containing urofollitropin, registered in Denmark by IBSA Farmaceutici Italia S.r.l. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Urofollitropin is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA04 (urofollitropin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Urofollitropin · ATC G03GA04
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- UROFOLLITROPIN
- Manufacturer
- IBSA Farmaceutici Italia S.r.l
- Country
- Denmark (DK)
- ATC code
- G03GA04
- ATC class
- Urofollitropin
- Defined daily dose
- 75 E, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104919111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for urofollitropin.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Urofollitropin · interactions on record
1 record
- 1 moderate
Most severe, free to view
- GanirelixH01CC01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G03GA04
Urofollitropin, as other registers publish it.
- United KingdomBravelle 75unit powder and solvent for solution for injection vialsFerring Pharmaceuticals Ltd
- FinlandFertinorm HpLaboratoires Serono S.A.
- FinlandFertinorm HpLaboratoires Serono S.A.
- FinlandFollegonN.V. Organon
- DenmarkFostimonIBSA Farmaceutici Italia S.r.l
- PolandFostimonIBSA Farmaceutici Italia S.r.l.
- FinlandFostimonIBSA Farmaceutici Italia S.r.l
- FinlandFostimonIBSA Farmaceutici Italia S.r.l
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/479ecd04-c304-4244-b970-a327d4a07e1b GET /v1/drugs/479ecd04-c304-4244-b970-a327d4a07e1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "75 IE",
"auth_role": "CMS",
"dk_drugid": "28104919111",
"substance": "UROFOLLITROPIN",
"auth_procedure": "MRP",
"in_medicinpriser": false,
"registration_date_serial": "40885"
}See everything about urofollitropin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.